Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
- PMID: 30285691
- PMCID: PMC6171184
- DOI: 10.1186/s12893-018-0417-0
Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
Abstract
Background: The lymph node ratio (LNR), i.e. the number of positive lymph nodes (LN) divided by the total number of analyzed LN, has been described as a strong outcome predictor in node-positive colon cancer patients. However, most published analyses are constrained by relatively low numbers of analyzed LN. Therefore, the objective of the present study was to evaluate the prognostic impact of LNR in colon cancer patients with high numbers of analyzed LN.
Methods: One hundred sixty-six colon cancer patients underwent open colon resection. All node-positive patients were analyzed for this study. The number of analyzed LN, of positive LN, the disease-free (DFS) and overall survival (OS) time were prospectively recorded. Patients were dichotomously allocated to a high or a low LNR-group, respectively, with the median LNR (0.125) as a cut-off value. Median follow-up was 34.3 months.
Results: Fifty-eight patients (34.9%) were node-positive. The median number of analyzed LN was 23 (range 8-54). DFS and OS were significantly shorter in pN2 vs pN1 patients (p < 0.001, and p = 0.001, respectively), and in LNR high vs low patients (p = 0.032, and p = 0.034, respectively). pN2 (vs pN1) disease showed hazard ratios (HR) of 6.2 (p < 0.001), and 6.8 (p < 0.005; for DFS and OS, respectively), while LNR high (vs low) showed HR of 3.0 (p =0.041), and 4.5 (p = 0.054).
Conclusions: LNR is a reasonable outcome predictor in node-positive colon cancer patients. However, LNR is inferior to pN-stage in predicting survival in patients with high number of harvested lymph nodes.
Keywords: Colon cancer; Lymph node ratio; Outcome; pN-stage.
Conflict of interest statement
Ethics approval and consent to participate
The study has been approved by the regional Ethic committees of Basel (#201/00), Bern (#30/2001), and Olten (#EKO-0026). A written consent was signed by every participant.
Consent for publication
Not Applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection.Br J Cancer. 2015 Jul 14;113(2):212-9. doi: 10.1038/bjc.2015.211. Epub 2015 Jun 16. Br J Cancer. 2015. PMID: 26079302 Free PMC article.
-
Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio.J Surg Oncol. 2009 Sep 1;100(3):240-3. doi: 10.1002/jso.21273. J Surg Oncol. 2009. PMID: 19330780
-
Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.World J Surg Oncol. 2018 Sep 13;16(1):186. doi: 10.1186/s12957-018-1483-6. World J Surg Oncol. 2018. PMID: 30213260 Free PMC article.
-
Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review.Eur J Surg Oncol. 2021 Jun;47(6):1267-1277. doi: 10.1016/j.ejso.2021.01.004. Epub 2021 Jan 28. Eur J Surg Oncol. 2021. PMID: 33549378
-
Prognostic Value of Lymph Node Ratio in Cutaneous Melanoma: A Systematic Review.Cureus. 2021 Oct 29;13(10):e19117. doi: 10.7759/cureus.19117. eCollection 2021 Oct. Cureus. 2021. PMID: 34868763 Free PMC article. Review.
Cited by
-
Assessing the clinical utility of tumor invasion proportion of lymph nodes for enhanced risk stratification in N1 colorectal cancer.Am J Cancer Res. 2024 Dec 15;14(12):5826-5838. doi: 10.62347/DFXC4525. eCollection 2024. Am J Cancer Res. 2024. PMID: 39803664 Free PMC article.
-
A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.Biomedicines. 2022 Feb 1;10(2):340. doi: 10.3390/biomedicines10020340. Biomedicines. 2022. PMID: 35203549 Free PMC article.
-
Analysis of the predictive postoperative recurrence performance of three lymph node staging systems in patients with colon cancer.Front Oncol. 2025 Mar 11;15:1545082. doi: 10.3389/fonc.2025.1545082. eCollection 2025. Front Oncol. 2025. PMID: 40134603 Free PMC article.
-
Evaluation of prognostic factors and clinicopathological patterns of recurrence after curative surgery for colorectal cancer.World J Gastrointest Surg. 2021 Jan 27;13(1):50-75. doi: 10.4240/wjgs.v13.i1.50. World J Gastrointest Surg. 2021. PMID: 33552394 Free PMC article.
-
Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study.Front Surg. 2022 Aug 25;9:929576. doi: 10.3389/fsurg.2022.929576. eCollection 2022. Front Surg. 2022. PMID: 36090338 Free PMC article.
References
-
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer staging manual. 7. New York: Springer-Verlag; 2010.
-
- Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumors. 7. New York: Wiley-Blackwell; 2009.
-
- Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists. Consensus statement 1999. Arch Pathol Lab Med. 2000;124(7):979–994. - PubMed
-
- Lu Yen-Jung, Lin Pei-Ching, Lin Chun-Chi, Wang Huann-Sheng, Yang Shung-Haur, Jiang Jeng-Kai, Lan Yuan-Tzu, Lin Tzu-Chen, Liang Wen-Yi, Chen Wei-Shone, Lin Jen-Kou, Chang Shih-Ching. The Impact of the Lymph Node Ratio is Greater than Traditional Lymph Node Status in Stage III Colorectal Cancer Patients. World Journal of Surgery. 2013;37(8):1927–1933. doi: 10.1007/s00268-013-2051-4. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous